Health

Advertisement

Health

Government caution cools India's GLP-1 obesity drug surge?

India's GLP-1 anti-obesity drug market has neared Rs 1,906 crore as growth begins to moderate after a rapid surge. Physicians and industry executives say government advisories and tighter patient selection are steering the market towards more disciplined, prescription-led expansion.

What after GLP drugs: How big pharma are gearing up for the next game-changer after the weight-loss drug boom
advertisement

Health

What's the hype behind 'Gond Katira'?

Gond katira's popularity has surged across social media, with videos pitching it as a summer coolant and bone health aid. Experts say there is no strong evidence for those claims, though its fibre may support gut health.

gond-katira-100059256-16x9.jpg

Health

New drug may protect muscles during GLP-1 weight loss

Apitegromab reduced muscle loss by more than half when used with tirzepatide in an early clinical trial. The findings raise hopes of protecting muscle health as GLP-1 medicines gain ground for weight loss and diabetes.

In the TRIUMPH-1 study, patients receiving the highest 12 mg dose of retatrutide lost an average of 31.9 kg, or 28.3% of their body weight, over 80 weeks.
advertisement

Health

TheLiverDoc says his Instagram posts criticising homeopathy are blocked

A fresh controversy has erupted after hepatologist and social media educator TheLiverDoc claimed that one of his Instagram posts criticising homeopathy was blocked in India. The development has reignited debate over scientific criticism, free speech and the regulation of alternative medicine.

Health

Why does the same meal affect weight differently?

Many people dream of losing 10 kilos in just a few months, but experts say rapid weight loss comes with serious challenges. Studies explain why the speed of your weight loss journey matters just as much as the result.

advertisement
Load More